In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances
Top Cited Papers
Open Access
- 12 March 2026
- journal article
- review article
- Published by Wiley in Protein Science
- Vol. 35 (4) , e70525
Abstract
Oligomeric assemblies of amyloidogenic proteins, such as Aβ, tau, α‐synuclein, amylin, transthyretin, and TDP‐43, are increasingly recognized as key drivers of cellular dysfunction across a range of neurodegenerative and systemic disorders. However, their molecular properties remain poorly understood due to their low abundance, structural heterogeneity, and transient nature. This review outlines current methods for studying amyloid oligomers, including biophysical (NMR, cryo‐EM, HS‐AFM, mass spectrometry), computational (molecular dynamics simulations), and biological (cellular assays, organoids, and animal models) approaches. This review also covers emerging methods for detecting misfolded proteins within complex biological environments and live‐cell systems. Furthermore, we discuss recent advances that specifically address the challenges of studying oligomers, which are yielding crucial data on how these pathogenic species impair cellular homeostasis. Given the heterogeneity and transient nature of the oligomers, it is essential to utilize findings across diverse experimental platforms that yield complementary data and apply methods that also ensure reproducibility and mechanistic clarity with the goal of translating these findings into effective therapeutic strategies.Keywords
Funding Information
- National Institutes of Health (R01DK132214)
- National Science Foundation (DMR‐2128556)
This publication has 298 references indexed in Scilit:
- Making tau amyloid models in vitro: a crucial and underestimated challengeFEBS Letters, 2025
- Nanoscale flow cytometry‐based quantification of blood‐based extracellular vesicle biomarkers distinguishes MCI and Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Cryo‐electron Microscopy Imaging of Alzheimer's Amyloid‐beta 42 Oligomer Displayed on a Functionally and Structurally Relevant ScaffoldAngewandte Chemie International Edition, 2021
- Probing the Interaction of Huntingtin Exon‐1 Polypeptides with the Chaperonin Nanomachine GroELChemBioChem, 2021
- Detection of TDP‐43 oligomers in frontotemporal lobar degeneration–TDPAnnals of Neurology, 2015
- Solution NMR Studies of Recombinant Aβ(1–42): From the Presence of a Micellar Entity to Residual β‐Sheet Structure in the Soluble SpeciesChemBioChem, 2015
- A Hexameric Peptide Barrel as Building Block of Amyloid‐β ProtofibrilsAngewandte Chemie International Edition, 2014
- Characterizing Methyl‐Bearing Side Chain Contacts and Dynamics Mediating Amyloid β Protofibril Interactions Using 13Cmethyl‐DEST and Lifetime Line BroadeningAngewandte Chemie International Edition, 2014
- Amyloid‐beta oligomerization in Alzheimer dementia versus high‐pathology controlsAnnals of Neurology, 2012
- Minireview: Structural insights into early folding events using continuous‐flow time‐resolved small‐angle X‐ray scatteringBiopolymers, 2011